Jump to content

Advocacy Opportunity: NSCLC Stage 3B, 3C or 4

Recommended Posts

Advocacy Opportunity, contact information below:

"IQVIATM (www.iqvia.com), in partnership with GlaxoSmithKline (GSK), a pharmaceutical company, is currently conducting a research study with patients who have been diagnosed with advanced (stage IIIb, IIIc, or IV) non-small cell lung cancer (NSCLC) by their physician. The study will involve participating in a telephone interview lasting 45-60 minutes.

In appreciation of your time, we are offering an honorarium.

The research will focus on understanding the NSCLC patient experience. This research may help improve how the patient experience is accounted for in clinical trials for new treatments of NSCLC.

The interviews can be scheduled during a time that is convenient for you as we have a range of different time slots.

The study is strictly for research purposes; there will be absolutely no sales or promotional activities. The aim of this research is to gain your views and is not in any way promotional.

If you are interested, or have any questions, please contact at veronica@global-patients.com"

Link to comment
Share on other sites

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.